General Surgery Resident
University of Michigan
Ann Arbor, Michigan
Sriganesh is a general surgery resident at the University of Michigan. He completed his undergraduate studies in Biology (B.S., 2009) and Chemistry (B.S., 2009) at West Virginia University, where he graduated with honors. He subsequently completed his MD and PhD (Department of Biochemistry; Section of Cancer Cell Biology) at West Virginia University (Morgantown Campus) in 2017 and was inducted into Alpha Omega Alpha (AOA). His doctoral research focused on post-transcriptional regulation of RAS and effector pathway signaling in triple negative breast cancers and was important in describing non-redundant roles for mediators of RAS signaling in cells harboring mutant and wildtype RAS oncogenes. During his time as an MD-PhD student, Sriganesh was an active member in the American Physician Scientists Association (APSA).
Sriganesh is currently in his academic development time, during which he is a post-doctoral fellow at the Conrad Jobst Vascular Laboratory under the mentorship of Dr. Andrea Obi and Dr. Peter Henke. His active projects focus delineating the epigenetic regulation of innate cell signaling in mediating host responses after coronavirus infection and identifying targetable signaling pathways to curb COVID-associated coagulopathy (CAC) and macrophage activation syndrome (MAS). His work has earned recognition by the Fredrick A. Coller Surgical Society, the American Academy of Immunology, the International Society of Thrombosis and Hemostasis, and the Society of Vascular Surgery. Sriganesh hopes to further study the immunobiology of pulmonary thromboembolic disease and thoracic cancer cell signaling and is an aspiring cardiothoracic surgeon-basic scientist.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Wednesday, June 15, 2022
8:00 AM – 8:10 AM EDT